Pharmacological interventions for promoting smoking cessation during pregnancy

Cochrane Database of Systematic Reviews

Volumn 2020, Issue 3, 2020, Pages

  Claire, Ravinder ^a   Chamberlain, Catherine ^b   Davey, Mary Ann ^c   Cooper, Sue E ^a   Berlin, Ivan ^d   Leonardi Bee, Jo ^a   Coleman, Tim ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b LA TROBE UNIVERSITY   (Australia)

^c MONASH UNIVERSITY   (Australia)

^d SORBONNE UNIVERSITÉ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; NICOTINE; PLACEBO; NICOTINIC AGENT;

BIRTH WEIGHT; CESAREAN SECTION; CHILDBIRTH; CLINICAL EFFECTIVENESS; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; HOSPITAL ADMISSION; HUMAN; INTERVENTION STUDY; LOW BIRTH WEIGHT; LOW DRUG DOSE; META ANALYSIS; NEONATAL INTENSIVE CARE UNIT; NEWBORN DEATH; NICOTINE REPLACEMENT THERAPY; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; REVIEW; SELF REPORT; SMOKING CESSATION; SPONTANEOUS ABORTION; STILLBIRTH; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; TREATMENT DURATION; FEMALE; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PROCEDURES; RANDOMIZED CONTROLLED TRIAL (TOPIC); SMOKING; THERAPY;

BUPROPION; FEMALE; HUMANS; NICOTINIC AGONISTS; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SMOKING; SMOKING CESSATION; TOBACCO USE CESSATION DEVICES;

EID: 85081042765     PISSN: None     EISSN: 1469493X     Source Type: Journal    
DOI: 10.1002/14651858.CD010078.pub3     Document Type: Review

References (164)

1. Berlin I, Golmard JL, Jacob N, Tanguy ML, Heishman SJ. Cigarette smoking during pregnancy: do complete abstinence and low level cigarette smoking have similar impact on birth weight?. Nicotine & Tobacco Research 2017;19(5):518-24. x-wiley/crsRef/12915249
2. Berlin I, Grange G, Jacob N, Tanguy ML. Nicotine patches in pregnant smokers: randomised, placebo controlled, multicentre trial of efficacy. BMJ 2014;348:1622. x-wiley/crsRef/12915250
3. Claire R, Coleman T, Leonardi-Bee J, Berlin I. Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches. Addiction 2019;114(9):1651-8. x-wiley/crsRef/12915251
4. NCT00507975. Study of Nicotine Patch in Pregnancy (SNIPP). clinicaltrials.gov/ct2/show/NCT00507975 (first received 27 July 2007). x-wiley/crsRef/3001417
5. Bowker KA, Lewis S, Coleman T, Vaz LR, Cooper S. Comparison of cotinine levels in pregnant women whilst smoking and when using nicotine replacement therapy. Nicotine & Tobacco Research 2014;16(6):895-8. x-wiley/crsRef/3001419
6. Coleman T, Cooper S, Thornton JG, Grainge MJ, Watts K, Britton J, et al. Smoking, Nicotine, and Pregnancy (SNAP) Trial Team. A randomized trial of nicotine-replacement therapy patches in pregnancy. New England Journal of Medicine 2012;366:808-18. x-wiley/crsRef/3001420
7. Coleman T, Thornton J, Britton J, Lewis S, Watts K, Coughtrie MW, et al. Protocol for the smoking, nicotine and pregnancy (SNAP) trial: double-blind, placebo-randomised, controlled trial of nicotine replacement therapy in pregnancy. BMC Health Services Research 2007;3(7):2. x-wiley/crsRef/3001421
8. Cooper S, Lewis S, Thornton JG, Marlow N, Watts K, Britton J, et al. Smoking, Nicotine and Pregnancy Trial Team. The SNAP trial: a randomised placebo-controlled trial of nicotine replacement therapy in pregnancy - clinical effectiveness and safety until 2 years after delivery, with economic evaluation. Health Technology Assessment 2014;18(54):1-128. x-wiley/crsRef/3001422
9. Cooper S, Taggar J, Lewis S, Marlow N, Dickinson A, Whitemore R, et al. Smoking, Nicotine and Pregnancy (SNAP) Trial Team. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial. Lancet Respiratory Medicine 2014;2(9):728-37. x-wiley/crsRef/3001423
10. Essex HN, Parrott S, Wu Q, Li J, Cooper S, Coleman T. Cost-effectiveness of nicotine patches for smoking cessation in pregnancy: a placebo randomised controlled trial (SNAP). Nicotine & Tobacco Research 2014;17(6):636-42. x-wiley/crsRef/3001424
11. Grainge M, Coleman T, Cooper S, Thornton J, Watts K, Britton J, et al. Double-blind, placebo-controlled randomised trial of nicotine replacement therapy patches in pregnancy. Journal of Perinatal Medicine 2012;39 Suppl:172. x-wiley/crsRef/3001425
12. Thornton JG, Coleman T, Britton J, Cooper S, Watts K, Lewis S, et al. The smoking, nicotine and pregnancy (SNAP) trial: main results. Archives of Disease in Childhood: Fetal and Neonatal Edition 2011;96(Suppl 1):Fa109. x-wiley/crsRef/12915252
13. Vaz LR, Aveyard P, Cooper S, Leonardi-Bee J, Coleman T. The association between treatment adherence to nicotine patches and smoking cessation in pregnancy: a secondary analysis of a randomized controlled trial. Nicotine & Tobacco Research 2016;18(10):1952-9. x-wiley/crsRef/12915253
14. Vaz LR, Coleman T, Cooper S, Aveyard P, Leonardi-Bee J. The nicotine metabolite ratio in pregnancy measured by trans-3'-hydroxycotinine to cotinine ratio: characteristics and relationship with smoking cessation. Nicotine & Tobacco Research 2015;17(11):1318-23. x-wiley/crsRef/12915254
15. El-Mohandes AAE, Windsor R, Tan S, Perry D, Gantz M, Kiely M. A randomized clinical trial of trans-dermal nicotine replacement in pregnant African-American smokers. Maternal & Child Health Journal 2013;17(5):897-906. x-wiley/crsRef/3001428
16. NCT00341432. Effectiveness of nicotine replacement therapy in reducing the risk of nicotine exposure in pregnant minority smokers. clinicaltrials.gov/ct2/show/NCT00341432?term=NCT00341432&rank=1) (first received 21 June 2006). x-wiley/crsRef/3001429
17. Atkinson E, Hotham L, Baghurst P. Nicotine replacement therapy as an adjunct to smoking cessation counselling in pregnancy: a randomised study to evaluate efficacy in an antenatal clinic setting. Australian and New Zealand Journal of Obstetrics and Gynaecology 2003;43(2):177-87. x-wiley/crsRef/3001431
18. Hotham ED, Gilbert AL, Atkinson ER. A randomised-controlled pilot study using nicotine patches with pregnant women. Addictive Behaviors 2006;31(4):641-8. x-wiley/crsRef/3001432
19. Hotham ED, Gilbert AL, Atkinson ER. Case studies of three pregnant smokers and their use of nicotine replacement therapy. Midwifery 2005;21(3):224-32. x-wiley/crsRef/3001433
20. Kapur B, Hackman R, Selby P, Klein J, Koren G. Randomized, double-blind, placebo-controlled trial of nicotine replacement therapy in pregnancy. Current Therapeutic Research - Clinical and Experimental 2001;62(4):274-8. x-wiley/crsRef/3001435
21. Nanovskaya T, Fokina VM, West H, Oncken C, Ahmed MS, Hankins G. Initial assessment of smoking status of pregnant women enrolled in a clinical trial for smoking cessation. Drug and Alcohol Dependence 2017;100(171):e150-1. x-wiley/crsRef/12915256
22. Nanovskaya TN, Oncken C, Fokina VM, Feinn RS, Clark SM, West H, et al. Bupropion sustained release for pregnant smokers: a randomized, placebo-controlled trial. American Journal of Obstetrics & Gynecology 2017;216(4):420.e1-e9. x-wiley/crsRef/12915257
23. Oncken C, Dornelas E, Greene J, Sankey H, Glasmann A, Feinn R, et al. Nicotine gum for pregnant smokers: a randomized controlled trial. Obstetrics & Gynecology 2008;112(4):859-67. x-wiley/crsRef/3001437
24. Oncken C, Dornelas E, Greene J, Sankey H, Glasmann A, Kranzler HR. Nicotine gum for pregnant smokers: a randomized controlled trial. 70th Annual Scientific Meeting of the College on Problems on Drug Dependence; 2008 June 14-19; San Juan, Puerto Rico. 2008:143. x-wiley/crsRef/3001438
25. Oncken C, Dornelas EA, Kuo CL, Sankey HZ, Kranzler HR, Mead EL, et al. Randomized trial of nicotine inhaler for pregnant smokers. American Journal of Obstetrics & Gynecology MFM 2019;1(1):19-23. [DOI: 10.1016/j.ajogmf.2019.03.006]x-wiley/crsRef/12915259
26. Fish LJ, Peterson BL, Namenek-Brouwer RJ, Lyna P, Oncken CA, Swamy GK, et al. Adherence to nicotine replacement therapy among pregnant smokers. Nicotine & Tobacco Research 2009;11(5):514-8. x-wiley/crsRef/3001440
27. Pollak KI, Oncken CA, Lipkus IM, Lyna P, Swamy GK, Pletsch PK, et al. Nicotine replacement and behavioral therapy for smoking cessation in pregnancy. American Journal of Preventive Medicine 2007;33(4):297-305. x-wiley/crsRef/3001441
28. Pollak KI, Oncken CA, Lipkus IM, Peterson BL, Swamy GK, Pletsch PK, et al. Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trial. Nicotine & Tobacco Research 2006;8(4):547-54. x-wiley/crsRef/3001442
29. Pollak KI, Oncken CA, Lipkus IM, Peterson BL, Swamy GK, Pletsch PK, et al. Effectiveness of adding nicotine replacement therapy to cognitive behavioural therapy for smoking cessation in pregnant smokers: the Baby Steps Trial. Society for Research on Nicotine and Tobacco 13th Annual Meeting; 2007 Feb 21-24; Austin, Texas. 2007:25, Abstract no: PA6-3. x-wiley/crsRef/3001443
30. Swamy GK, Roelands JJ, Peterson BL, Fish LJ, Oncken CA, Pletsch PK, et al. Predictors of adverse events among pregnant smokers exposed in a nicotine replacement therapy trial. American Journal of Obstetrics & Gynecology 2009;201:354.e1-e7. x-wiley/crsRef/3001444
31. NCT01286402. Double blind, placebo-controlled pilot study of Bupropion to promote smoking cessation during pregnancy. https://clinicaltrials.gov/ct2/show/NCT01286402 (first received 4 February 2016). x-wiley/crsRef/3001446
32. Stotts AL, Northrup TF, Cinciripini PM, Minnix JA, Blalock JA, Mullen PD, et al. Randomized, controlled pilot trial of bupropion for pregnant smokers: challenges and future directions. American Journal of Perinatology 2015;32(4):351-6. x-wiley/crsRef/3001447
33. Wisborg K. Nicotine patches to pregnant smokers - a randomised study. 1st International Conference of the Society for Research on Nicotine and Tobacco; 1998 Aug 22-23; Copenhagen. 1998. x-wiley/crsRef/3001450
34. Wisborg K, Henriksen TB, Jespersen LB, Secher NJ. Nicotine patches for pregnant smokers: a randomized controlled study. Obstetrics & Gynecology 2000;96(6):967-71. x-wiley/crsRef/3001449
35. Eades SJ, Sanson-Fisher RW, Wenitong M, Panaretto K, D'Este C, Gilligan C, et al. An intensive smoking intervention for pregnant Aboriginal and Torres Strait Islander women: a randomised controlled trial. Medical Journal of Australia 2012;197(1):42-6. x-wiley/crsRef/12915261
36. Gilligan C. A Pilot Randomised Controlled Trial to Test the Effectiveness of an Intervention to Help Aboriginal and Torres Strait Islander Women to Quit Smoking During Pregnancy: Study Design and Preliminary Results [thesis]. Newcastle, Australia: University of Newcastle, 2008. x-wiley/crsRef/12915262
37. Bar-Zeev Y, Bonevski B, Bovill M, Gruppetta M, Oldmeadow C, Palazzi K, et al. The Indigenous Counselling and Nicotine (ICAN) QUIT in Pregnancy Pilot Study protocol: a feasibility step-wedge cluster randomised trial to improve health providers' management of smoking during pregnancy. BMJ Open 2017;7(8):e016095. x-wiley/crsRef/12915264
38. Gould GS, Bovill M, Pollock L, Bonevski B, Gruppetta M, Atkins L, et al. Feasibility and acceptability of Indigenous Counselling and Nicotine (ICAN) QUIT in Pregnancy multicomponent implementation intervention and study design for Australian Indigenous pregnant women: a pilot cluster randomised step-wedge trial. Addictive Behaviors 2019;90:176-90. x-wiley/crsRef/12915265
39. Hegaard HK, Kjaergaard H, Moller LF, Wachmann H, Ottesen B. Multimodal intervention raises smoking cessation rate during pregnancy. Acta Obstetricia et Gynecologica Scandinavica 2003;82(9):813-9. x-wiley/crsRef/12915267
40. NCT00744913. Study of nicotine replacement therapy in pregnancy [Randomized, controlled open-label study of nicotine replacement therapy in pregnancy]. clinicaltrials.gov/show/NCT00744913 (first received 1 September 2008). x-wiley/crsRef/12915269
41. NCT00888979. Pilot study of nicotine replacement for smoking cessation during pregnancy. clinicaltrials.gov/show/NCT00888979 (first received 28 April 2009). x-wiley/crsRef/12915271
42. Oncken C, Campbell W, Chan G, Hatsukami D, Kranzler HR. Effects of nicotine patch or nasal spray on nicotine and cotinine concentrations in pregnant smokers. Journal of Maternal-Fetal and Neonatal Medicine 2009;22(9):751-8. x-wiley/crsRef/12915273
43. ACTRN12618000972224. SISTAQUIT (Supporting Indigenous Smokers to Assist Quitting) [SISTAQUIT (Supporting Indigenous Smokers to Assist Quitting): a cluster randomised controlled trial to improve strategies for the management of smoking cessation in pregnant Aboriginal and/or Torres Strait Islander women]. www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=374707 (first received 20 March 2018). x-wiley/crsRef/12915275
44. IRCT20181209041904N1. Comparison of the effectiveness of treatment with nicotine patches versus support behavior in smoking cessation in pregnant women. en.irct.ir/trial/35928 (first received 21 December 2018). x-wiley/crsRef/12915277
45. ISRCTN62025374. Helping pregnant smokers quit: a multi-centre study of electronic cigarettes and nicotine patches [Helping pregnant smokers quit: a multi-centre randomised controlled trial of electronic cigarettes and nicotine patches]. www.isrctn.com/ISRCTN62025374 (first received 20 March 2017). x-wiley/crsRef/12915279
46. NCT01875172. Bupropion for smoking cessation in pregnancy [Smoking cessation in pregnancy: a pilot study comparing counseling with and without sustained-release bupropion]. clinicaltrials.gov/show/NCT01875172 (first received 11 June 2013). x-wiley/crsRef/12915281
47. NCT02188459. Placebo-controlled trial of bupropion for smoking cessation in pregnant women (BIBS) [Placebo-controlled trial of bupropion for smoking cessation in pregnant women]. clinicaltrials.gov/show/NCT02188459 (first received 11 July 2014). x-wiley/crsRef/12915283
48. Al-Sahab B, Saqib M, Hauser G, Tamim H. Prevalence of smoking during pregnancy and associated risk factors among Canadian women: a national survey. BMC Pregnancy and Childbirth 2010;10:24. [DOI: 10.1186/1471-2393-10-24]
49. Andreski P, Breslau N. Maternal smoking among blacks and whites. Social Science and Medicine 1995;41(2):227-33.
50. Aveyard R, West R. Managing smoking cessation. BMJ 2007;335:37-41.
51. Barbeau AM, Burda J, Siegel M. Perceived efficacy of e-cigarettes versus nicotine replacement therapy among successful e-cigarette users: a qualitative approach. Addiction Science & Clinical Practice 2013;8(1):5.
52. Baric L, MacArthur C. Health norms in pregnancy. British Journal of Preventive and Social Medicine 1977;31(1):30-8.
53. Belbasis L, Savvidou MD, Kanu C, Evangelou E, Tzoulaki I. Birth weight in relation to health and disease in later life: an umbrella review of systematic reviews and meta-analyses. BMC Medicine 2016;14(1):147.
54. Benowitz NL, Dempsey DA, Goldenberg RL, Hughes JR, Dolan-Mullen P, Ogburn PL, et al. The use of pharmacotherapies for smoking cessation during pregnancy. Tobacco Control 2000;9 Suppl 3(0964-4563):III91-4.
55. Bentley JP, Roberts CL, Bowen JR, Martin AJ, Morris JM, Nassar N. Planned birth before 39 weeks and child development: a population-based study. Pediatrics 2016;138(6):e20162002.
56. Blalock JA, Fouladi RT, Wetter DW, Cinciripini PM. Depression in pregnant women seeking smoking cessation treatment. Addictive Behaviors 2005;30(6):1195-208.
57. Blalock JA, Nayak N, Wetter DW, Schreindorfer L, Minnix JA, Canul J, et al. The relationship of childhood trauma to nicotine dependence in pregnant smokers. Psychology of Addictive Behaviors 2011;25(4):652.
58. Bruin JE, Gerstein HC, Holloway AC. Long-term consequences of fetal and neonatal nicotine exposure: a critical review. Toxicological Sciences 2010;116(2):364-74.
59. Bush J, White M, Kai J, Rankin J, Bhopal R. Understanding influences on smoking in Bangladeshi and Pakistani adults: community based, qualitative study. BMJ 2003;326:962.
60. Cahill K, Lindson-Hawley N, Thomas KH, Fanshawe TR, Lancaster T. Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews 2016, Issue 5. [DOI: 10.1002/14651858.CD006103.pub7]
61. CAN-ADAPTT. Canadian smoking cessation clinical practise guideline: summary statements. www.peelregion.ca/health/professionals/events/pdf/2013/canadaptt-summary-statements.pdf.
62. Centers for Disease Control and Prevention. Women and smoking: a report of the Surgeon General (executive summary). Morbidity and Mortality Weekly Report 51 (No. RR-12) 2002; Vol. 51, issue RR-12.
63. Chamberlain C, O'Mara-Eves A, Porter J, Coleman T, Perlen SM, Thomas J, et al. Psychosocial interventions for supporting women to stop smoking in pregnancy. Cochrane Database of Systematic Reviews 2017, Issue 2. [DOI: 10.1002/14651858.CD001055.pub5]
64. Chan A, Keane RJ, Robinson JS. The contribution of maternal smoking to preterm birth, small for gestational age and low birth weight among aboriginal and non-aboriginal births in South Australia. Medical Journal of Australia 2001;174(8):389-93.
65. Claire R, Coleman T, Leonardi-Bee J, Berlin I. Saliva cotinine concentrations in pregnant women who smoke and use nicotine patches. Addiction 2019;114(9):1651-8.
66. Claire R, Cooper SE, Leonardi-Bee J, Coleman T, Davey M-A, Chamberlain C, et al. Pharmacological interventions for promoting smoking cessation during pregnancy. www.crd.york.ac.uk/prospero/display_record.php?ID=CRD42019140195.
67. Cnattingius S. The epidemiology of smoking during pregnancy: smoking prevalence, maternal characteristics, and pregnancy outcomes. Nicotine & Tobacco Research 2004;6(S2):S125-40.
68. Cobb NK, Byron MJ, Abrams DB, Shields PG. Novel nicotine delivery systems and public health: the rise of the "e-cigarette". American Journal of Public Health 2010;100(12):2340-2.
69. Coe JW, Brooks PR, Vetelino MG, Wirtz MC, Arnold EP, Huang J, et al. Varenicline: an alpha4beta2 nicotinic receptor partial agonist for smoking cessation. Journal of Medicinal Chemistry 2005;48(10):3474-7.
70. Coleman T, Chamberlain C, Cooper S, Leonardi-Bee J. Efficacy and safety of nicotine replacement therapy for smoking cessation in pregnancy: systematic review and meta-analysis. Addiction 2011;106(1):52-61.
71. Cooper S, Taggar J, Lewis S, Marlow N, Dickinson A, Whitemore R, et al. Effect of nicotine patches in pregnancy on infant and maternal outcomes at 2 years: follow-up from the randomised, double-blind, placebo-controlled SNAP trial. Lancet Respiratory Medicine 2014;2(9):728-37.
72. Crawford JT, Tolosa JE, Goldenberg RL. Smoking cessation in pregnancy: why, how, and what next. Clinical Obstetrics and Gynecology 2008;51(2):419-35.
73. Crittenden KS, Manfredi C, Cho YI, Dolecek TA. Smoking cessation processes in low-SES women: the impact of time-varying pregnancy status, healthcare messages, stress and health concerns. Addictive Behaviors 2007;32(7):1347-66.
74. Cryan JF, Bruijnzeel AW, Skjei KL, Markou A. Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat. Psychopharmacology 2003;168(3):347-58.
75. Dempsey DA, Benowitz NL. Risks and benefits of nicotine to aid smoking cessation in pregnancy. Drug Safety 2001;24(4):277-322.
76. Dixon L, Aimer P, Fletcher L, Guilliland K, Hendry C. Smoke free outcomes with midwife lead maternity carers: an analysis of smoking during pregnancy from the New Zealand College of Midwives Midwifery database 2004-2007. New Zealand College of Midwives Journal 2009;40:13-9.
77. Ebert LM, Fahy K. Why do women continue to smoke in pregnancy?. Women and Birth 2007;20(4):161-8.
78. Filippidis FT, Laverty AA, Gerovasili V, Vardavas CI. Two-year trends and predictors of e-cigarette use in 27 European Union member states. Tobacco Control 2017;26(1):98-104.
79. Fish LJ, Peterson BL, Namenek Brouwer RJ, Lyna P, Oncken CA, Swamy GK, et al. Adherence to nicotine replacement therapy among pregnant smokers. Nicotine & Tobacco Research 2009;11(5):514-8.
80. Frost FJ, Cawthorn ML, Tollestrup K, Kenny FW, Schrager LS, Nordlund DJ. Smoking prevalence during pregnancy for women who are and women who are not Medicaid-funded. American Journal of Preventive Medicine 1994;10(2):91-6.
81. Fryer JD, Lukas RJ. Noncompetitive functional inhibition at diverse, human nicotinic acetylcholine receptor subtypes by bupropion, phencyclidine, and ibogaine. Journal of Pharmacology and Experimental Therapeutics 1999;288(1):88-92.
82. Gaither KH, Brunner-Huber LR, Thompson ME, Huet-Hudson YM. Does the use of nicotine replacement therapy during pregnancy affect pregnancy outcomes. Maternal and Child Health Journal 2009;13(4):497-504.
83. Gilligan C, Sanson-Fisher R, Eades S, D'Este C. Antenatal smoking in vulnerable population groups: an area of need. Journal of Obstetrics and Gynaecology 2007;27(7):664-71.
84. Giovino GA. The tobacco epidemic in the United States. American Journal of Preventive Medicine 2007;33(6 Suppl):S318-26.
85. Gluckman PD, Hanson MA, Cooper C, Thornburg KL. Effect of in-utero and early life conditions on adult health and disease. New England Journal of Medicine 2008;359(1):61-73.
86. McMaster University (developed by Evidence Prime). GRADEproGDT. Version accessed 13 January 2020. Hamilton (ON): McMaster University (developed by Evidence Prime).
87. Graham H. Smoking in pregnancy: the attitudes of pregnant mothers. Social Science and Medicine 1976;10(7-8):399-405.
88. Graham H. Smoking prevalence among women in the European community 1950-1990. Social Science and Medicine 1996;43(2):243-54.
89. Graham H, Hawkins SS, Law C. Lifecourse influences on women's smoking before, during and after pregnancy. Social Science and Medicine 2010;70(4):582-7.
90. Green NS, Damus K, Simpson JL, Iams J, Reece EA, Hobel CJ, et al. Research agenda for preterm birth: recommendations from the March of the Dimes. American Journal of Obstetrics and Gynecology 2005;193(3 Pt 1):626-35.
91. Hajek P, Phillips-Waller A, Przulj D, Pesola F, Myers Smith K, Bisal N, et al. A randomized trial of e-cigarettes versus nicotine-replacement therapy. New England Journal of Medicine 2019;380(7):629-37.
92. Hammoud AO, Bujold E, Sorokin Y, Schild C, Krapp M, Baumann P. Smoking in pregnancy revisited: findings from a large population-based study. American Journal of Obstetrics & Gynecology 2005;192(6):1856-63.
93. Hartmann-Boyce J, McRobbie H, Bullen C, Begh R, Stead LF, Hajek P. Electronic cigarettes for smoking cessation. Cochrane Database of Systematic Reviews 2016, Issue 9. [DOI: 10.1002/14651858.CD010216.pub3]
94. Hartmann-Boyce J, Chepkin SC, Ye W, Bullen C, Lancaster T. Nicotine replacement therapy versus control for smoking cessation. Cochrane Database of Systematic Reviews 2018, Issue 5. [DOI: 10.1002/14651858.CD000146.pub5]
95. Herrmann M, King K, Weitzman M. Prenatal tobacco smoke and postnatal secondhand smoke exposure and child neurodevelopment. Current Opinion in Pediatrics 2008;20(2):184-90.
96. Hickson C, Lewis S, Campbell KA, Cooper S, Berlin I, Claire R, et al. Comparison of nicotine exposure during pregnancy when smoking and abstinent with nicotine replacement therapy: systematic review and meta-analysis. Addiction 2019;114(3):406-24.
97. Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions version 6.0 (updated July 2019). Cochrane, 2019. Available from www.training.cochrane.org/handbook.
98. Hughes JR, Stead LF, Hartmann-Boyce J, Cahill K, Lancaster T. Antidepressants for smoking cessation. Cochrane Database of Systematic Reviews 2014, Issue 1. [DOI: 10.1002/14651858.CD000031.pub4]
99. Hunt J. Trying to Make a Difference: Improving Pregnancy Outcomes, Care and Services for Australian Indigenous Women [thesis]. Victoria: LaTrobe University, 2003.
100. Kaplan SD, Lanier AP, Merritt RK, Siegel PZ. Prevalence of tobacco use among Alaska natives: a review. Preventive Medicine 1997;26(4):460-5.
101. Kramer MS. Determinants of low birth weight: methodological assessment and meta-analysis. Bulletin of the World Health Organization 1987;65(5):663-737.
102. Kumar R, Gould GS. Tobacco harm reduction for women who cannot stop smoking during pregnancy - a viable option?. JAMA Pediatrics 2019;173(7):615-6.
103. Lange S, Probst C, Rehm J, Popova S. National, regional, and global prevalence of smoking during pregnancy in the general population: a systematic review and meta-analysis. Lancet Global Health 2018;6(7):e769-76.
104. Lanting CI, van Wouwe JP, van den Burg I, Segaar D, van der Pal-de Bruin KM. Smoking during pregnancy: trends between 2001 and 2010 [Roken tijdens de zwangerschap: trends in de periode 2001-2010]. Nederlands Tijdschrift Voor Geneeskunde 2012;156(46):A5092.
105. Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, et al. Mediating mechanisms for the impact of bupropion in smoking cessation treatment. Drug and Alcohol Dependence 2002;67(2):219-23.
106. Lindson N, Chepkin SC, Ye W, Fanshawe TR, Bullen C, Hartmann-Boyce J. Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation. Cochrane Database of Systematic Reviews 2019, Issue 4. [DOI: 10.1002/14651858.CD013308]
107. Liu L, Oza S, Hogan D, Chu Y, Perin J, Zhu J, et al. Global, regional, and national causes of under-5 mortality in 2000-15: an updated systematic analysis with implications for the Sustainable Development Goals. Lancet 2016;388(10063):3027-35.
108. Maritz GS. Are nicotine replacement therapy, varenicline or bupropion options for pregnant mothers to quit smoking? Effects on the respiratory system of the offspring. Therapeutic Advances in Respiratory Disease 2009;3(4):193-210.
109. Marufu TC, Ahankari A, Coleman T, Lewis S. Maternal smoking and the risk of still birth: systematic review and meta-analysis. BMC Public Health 2015;15(1):239.
110. McBride CM, Emmons KM, Lipkus IM. Understanding the potential of teachable moments: the case of smoking cessation. Health Education Research 2003;18(2):156-70.
111. McCowan LME, Dekker GA, Chan E, Stewart A, Chappell LC, Hunter M, et al. Spontaneous preterm birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study. BMJ 2009;338:b1081.
112. McNeill A, Brose LS, Calder R, Bauld L, Robson D. Evidence review of e-cigarettes and heated tobacco products 2018. A report commissioned by Public Health England. London: Public Health England; 2018 February.
113. National Institute for Clinical Excellence (NICE). Smoking: stopping in pregnancy and after childbirth [PH26]. London: NICE; 2010 June. London: National Institute for Clinical Excellence.
114. Notley C, Gentry S, Livingstone-Banks J, Bauld L, Perera R, Hartmann-Boyce J. Incentives for smoking cessation. Cochrane Database of Systematic Reviews 2019, Issue 7. [DOI: 10.1002/14651858.CD004307.pub6]
115. Oncken CA, Kranzler HR. What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy?. Nicotine & Tobacco Research 2009;11(11):1265-73.
116. Oncken CA, Dietz PA, Tong VT, Belizan JM, Tolosa JE, Berghella V, et al. Prenatal tobacco prevention and cessation interventions for women in low- and middle-income countries. Acta Obstetricia et Gynecologica Scandinavica 2010;89(4):442-53.
117. Oncken C, Ricci KA, Kuo CL, Dornelas E, Kranzler HR, Sankey HZ. Correlates of electronic cigarettes use before and during pregnancy. Nicotine & Tobacco Research 2017;19(5):585-90.
118. Pickett KE, Wilkinson RG, Wakschlag LS. The psychosocial context of pregnancy smoking and quitting in the Millennium Cohort Study. Journal of Epidemiology and Community Health 2009;63(6):474-80.
119. Polosa R, Caponnetto P, Morjaria JB, Papale G, Campagna D, Russo C. Effect of an electronic nicotine delivery device (e-Cigarette) on smoking reduction and cessation: a prospective 6-month pilot study. BMC Public Health 2011;11(1):786.
120. Potter A, Lumley J, Watson L. The 'new' risk factors for SIDS: is there an association with ethnic and place of birth differences in incidence in Victoria?. Early Human Development 1996;45:119-31.
121. Quinn VP, Mullen PD, Ershoff DH. Women who stop smoking spontaneously prior to prenatal care and predictors of relapse before delivery. Addictive Behaviors 1991;16(1-2):29-40.
122. The Royal Australian College of General Practitioners. Supporting smoking cessation: a guide for health professionals. www.racgp.org.au/FSDEDEV/media/documents/Clinical%20Resources/Guidelines/Supporting-smoking-cessation.pdf (accessed prior to 14 February 2020).
123. Royal Australian and New Zealand College of Obstetricians and Gynaecologists. Women and smoking. ranzcog.edu.au/RANZCOG_SITE/media/RANZCOG-MEDIA/Women%27s%20Health/Statement%20and%20guidelines/Clinical-Obstetrics/Women-and-Smoking-(C-Obs-53)-Review-November-2014_1.pdf?ext=.pdf (accessed prior to 14 February 2020).
124. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
125. Richmond R. You've come a long way baby: women and the tobacco epidemic. Addiction 2003;98(5):553-7.
126. Rore C, Brace V, Danielian P, Williams D. Smoking cessation in pregnancy. Expert Opinion on Drug Safety 2008;7(6):727-37.
127. Ryan P, Booth R, Coates D, Chapman A, Healy P. Experiences of Pregnancy. Pregnant Pause Campaign. Sydney: Health Commission of New South Wales, Division of Drug and Alcohol Services, 1980.
128. Salihu HM, Wilson RE. Epidemiology of prenatal smoking and perinatal outcomes. Early Human Development 2007;83(11):713-20.
129. Samet JM, Yoon SY. Women and the Tobacco Epidemic: Challenges for the 21st Century. Geneva: World Health Organization, 2001.
130. Schneider S, Schutz J. Who smokes during pregnancy? A systematic literature review of population-based surveys conducted in developed countries between 1997 and 2006. European Journal of Contraception and Reproductive Health Care 2008;13(2):138-47.
131. Schünemann H, Brożek J, Guyatt G, Oxman A, editor(s). Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach (updated October 2013). GRADE Working Group, 2013. Available from gdt.guidelinedevelopment.org/app/handbook/handbook.html.
132. Slemmer JE, Martin BR, Damaj MI, Slemmer JE, Martin BR, Damaj MI. Bupropion is a nicotinic antagonist. Journal of Pharmacology & Experimental Therapeutics 2000;295(1):321-7.
133. Small R. Mothers in a New Country (MINC) [thesis]. Victoria: LaTrobe University, 2000.
134. Squires J, Twombly E, Bricker D, Potter L. ASQ-3 User's Guide for the Ages and Stages Questionnaires. 3rd Edition. Baltimore: Paul H Brookes Publishing Co, 2009.
135. SRNT Subcommittee on Biochemical Verification. Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research 2002;4(2):149-59.
136. Stead LF, Hartmann-Boyce J, Perera R, Lancaster T. Telephone counselling for smoking cessation. Cochrane Database of Systematic Reviews 2013, Issue 8. [DOI: 10.1002/14651858.CD002850.pub2]
137. Stedman RL. The chemical composition of tobacco and tobacco smoke. Chemical Reviews 1968;68(2):153-207.
138. Tappin DM, Ford RP, Nelson KP, Wild CJ. Prevalence of smoking in early pregnancy by census area, measured by anonymous cotinine testing of residual antenatal blood samples. New Zealand Medical Journal 1996;109(1018):101-3.
139. Tappin DM, MacAskill S, Bauld L, Eadie D, Shipton D, Galbraith L. Smoking prevalence and smoking cessation services for pregnant women in Scotland. Substance Abuse: Treatment, Prevention, and Policy 2010;5. [DOI: 10.1186/1747-597X-5-1]
140. The NHS Information Centre (IFF Research). Infant feeding survey 2010. Early results. Health Care and Social Care Information Centre. London: The National Health Service Information Centre for Health and Social Care, 2011:1-22.
141. Tong VT, Jones JR, Dietz PM, D'Angelo D, Bombard JM. Trends in smoking before, during, and after pregnancy - Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005. Morbidity and Mortality Weekly Report 2009;58:1-29.
142. Troe EJ, Raat H, Jaddoe VW, Hofman A, Steegers EA, Verhulst FC, et al. Smoking during pregnancy in ethnic populations: the Generation R study. Nicotine & Tobacco Research 2008;10(8):1373-84. [PUBMED: 18686185]
143. Tsoi DT, Porwal M, Webster AC. Interventions for smoking cessation and reduction in individuals with schizophrenia. Cochrane Database of Systematic Reviews 2013, Issue 2. [DOI: 10.1002/14651858.CD007253.pub3]
144. Turner E, Jones M, Vaz LR, Coleman T. Systematic review and meta-analysis to assess the safety of bupropion and varenicline in pregnancy. Nicotine & Tobacco Research 2018;21(8):1001-10.
145. US Department of Health and Human Services. The Health Consequences of Smoking. 2004 Surgeon General's Report. US Department of Health and Human Services, 2004.
146. US Department of Health and Human Services. E-cigarette use among youth and young adults. A report of the Surgeon General. Atlanta (GA): US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2016.
147. Wanless D. Securing Good Health for the Whole Population. London: TSO, 2004.
148. West R, Shiffman S. Effect of oral nicotine dosing forms on cigarette withdrawal symptoms and craving: a systematic review. Psychopharmacology 2001;155(2):115-22.
149. West R, Hajek P, Stead L, Stapleton J, West R, Hajek P, et al. Outcome criteria in smoking cessation trials: proposal for a common standard. Addiction 2005;100(3):299-303.
150. West R, Baker CL, Cappelleri JC, Bushmakin AG. Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt. Psychopharmacology 2008;197(3):371-7.
151. World Health Organization. WHO Report on the Global Tobacco Epidemic, 2019. www.who.int/tobacco/global_report/en/.
152. Wiemann CM, Berenson AB, San Miguel VV. Tobacco, alcohol and illicit drug use among pregnant women: age and racial/ethnic differences. Journal of Reproductive Medicine 1994;39(10):769-76.
153. Woodby LL, Windsor RA, Snyder SW, Kohler CL, Diclemente CC. Predictors of smoking cessation during pregnancy. Addiction 1999;94(2):283-92.
154. Zhu SH, Zhuang YL, Wong S, Cummins SE, Tedeschi GJ. E-cigarette use and associated changes in population smoking cessation: evidence from US current population surveys. BMJ 2017;358:j3262.
155. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 2012, Issue 9. [DOI: 10.1002/14651858.CD010078]
156. Coleman T, Chamberlain C, Davey MA, Cooper SE, Leonardi-Bee J. Pharmacological interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 2015, Issue 12. [DOI: 10.1002/14651858.CD010078.pub2]
157. Lumley J. Advice as a strategy for reducing smoking in pregnancy. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM] The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
158. Lumley J. Behavioural strategies for reducing smoking in pregnancy. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM] The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
159. Lumley J. Counselling for reducing smoking in pregnancy. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM] The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
160. Lumley J. Feedback as a strategy for reducing smoking in pregnancy. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM] The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
161. Lumley J. Strategies for reducing smoking in pregnancy. In: Enkin MW, Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C (eds.) Pregnancy and Childbirth Module. In: The Cochrane Pregnancy and Childbirth Database [database on disk and CDROM] The Cochrane Collaboration; Issue 2, Oxford: Update Software; 1995.
162. Lumley J, Oliver S, Waters E. Interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 1999, Issue 4. [DOI: 10.1002/14651858.CD001055]
163. Lumley J, Oliver S, Chamberlain C, Oakley L. Interventions for promoting smoking cessation in pregnancy. Cochrane Database of Systematic Reviews 2004, Issue 4. [DOI: 10.1002/14651858.CD001055.pub2]
164. Lumley J, Chamberlain C, Dowswell T, Oliver S, Oakley L, Watson L. Interventions for promoting smoking cessation during pregnancy. Cochrane Database of Systematic Reviews 2009, Issue 3. [DOI: 10.1002/14651858.CD001055.pub3]